Washington · Nonprofit
ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES
ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES (Washington) receives grants from 1 organization whose IRS filings report $163,500 to it, the largest being AMERICAN CANCER SOCIETY INC ($163,500). 0 of them have funded it in more than one year.
- Revenue FY2024
- $26M
- Funders on record
- 1
- Grants received
- $164k
- Net assets
- $9.6M
What Altius Institute for Biomedical Sciences does
Mission
The mission of the Altius Institute for Biomedical Sciences (altius) is to advance the science of gene regulation for the benefit of human health. Altius aims to accomplish this mission by radically advancing biomedical discovery through the development and application of new technologies and approaches for illuminating cell and tissue functions in both health and disease states. To enable its mission, altius utilizes a new type of scientific and technological discovery environment designed to foster leaps in innovation by enabling its scientists to move from ideas to data faster than in any other academic or biotechnology setting. Altius continually strives to translate its data and technology into novel approaches for diagnosing and treating disease and for improving human health.
As stated on its FY2024 Form 990.
Program
Altius directly conducts an active and multifaceted program of basic biomedical research in the fields of genetics, genomics, and biotechnology. Most of this research happens in altius laboratories located in seattle, washington. The organization also collaborates with academic research hospitals. Altius aims to discover, develop, and translate for clinical use, both data and transformative technologies that illuminate or enable the control of human genes in medically important biological contexts. Altius research programs focus on gaining a richer understanding of how human cells function in health and disease for the purpose of developing new approaches to diagnosis and new therapies. Toward these goals, altius' research program focuses on the development, scaling and translational application of diverse technology platforms, including genetic and genomic analyses, cell and genome engineering, single molecule dna and chromatin analysis, high resolution cell imaging, and technologies for the design and delivery of gene control effectors. These platforms collectively provide new windows into cellular responses, and open new doors to the discovery of new medicines.
$25,686,537 spent100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $25,686,537.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $21M to $61M (+195%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2017 34% · 2018 30% · 2019 31% · 2020 17% · 2021 12% · 2022 3% · 2023 6% · 2024 5%. Grants only. Government contracts and fees sit inside program revenue.
101% of ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
Grant support over time, funder by funder — shade shows the grant size each year.
From the IRS filings of ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES draws 100% of its grant income from funders outside Washington, across 1 state in all.
Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES receives grants from 1 organization whose IRS filings report $164k to it.
this organization peer median middle 50% of peers· 4,580 health nonprofits $10M–$100M, FY2024
Government funding ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES receives
Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $25.4M on record.
- Department of Health and Human Services$25.4M
Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.
Organizations like ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Washington
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
80% of spending goes to programs.
Governance
Screen this organization
A dated, signed PDF of the compliance screen for ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES?
- ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES (Washington) receives grants from 1 organization whose IRS filings report $163,500 to it, the largest being AMERICAN CANCER SOCIETY INC ($163,500). 0 of them have funded it in more than one year.
- How many funders does ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES have?
- IRS filings report 1 organization giving $163,500 in grants to ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES.
- Who is the largest funder of ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES?
- AMERICAN CANCER SOCIETY INC is the largest funder on record, with $163,500 in grants. The full list of funders is on this page.
- How can an organization like ALTIUS INSTITUTE FOR BIOMEDICAL SCIENCES find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Washington. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Altius Institute for Biomedical Sciences →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing